Rhodopsin - Membrane Protein
The Blue Gene Science team at the IBM T.J. Watson Research Center selected membrane proteins for their initial work on Blue Gene/L because membrane processes enable cell signal detection, as well as ion and nutrient transport, and are the drug targets of the most of the world's major diseases. More than half the drug targets pursued by pharmaceutical companies are related to membrane-bound proteins. Diseases that are treated with drugs that target membrane proteins include: congestive heart failure, hypertension, stroke, cancer, ulcers, allergies, asthma, anxiety, psychosis, migraines and Parkinson's disease. [ Watch Video ] [ Get permission to re-use ]
If you have any feedback or questions, respond to webmaster@watson.ibm.com Copyright (c) 2009 by IBM Corporation. IBM, the IBM logo, and the IBM e-business Logo are registered trademarks of International Business Machines Corporation.
